Company / Interest Expense
GeneDx Holdings Corp. Interest Expense History
FY2019-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$2.5M
FY2022
5-year range
$2.5M / $2.8M
FY2019-FY2022
Trend
-12.7%
vs FY2021
Sector context
#41 of 43
Health Care
What the data says
Among 43 Health Care companies, GeneDx Holdings Corp. is in the top 5% for interest expense.
Based on SEC 10-K filings.
$2M in FY2022 with a 3-year CAGR of +46.7%.
Remained stable around $2M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +46.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 43This company $2.5M Sector average $324.8M
▼
-99.2% below sector average
Key checks
Key Insights
- 3-year CAGR of +46.7%, indicating consistent growth.
- In FY2022, interest expense decreased 12.7% year-over-year.
- Ranks #41 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $2.5M | -12.7% |
| FY2021 | $2.8M | +14.6% |
| FY2020 | $2.5M | +216.0% |
| FY2019 | $783.0K | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026